{"id":568126,"date":"2021-10-10T14:30:01","date_gmt":"2021-10-10T14:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=568126"},"modified":"2021-10-10T14:30:01","modified_gmt":"2021-10-10T14:30:01","slug":"burkitt-lymphoma-market-industry-analysis-drugs-pipeline-treatment-and-key-companies-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/burkitt-lymphoma-market-industry-analysis-drugs-pipeline-treatment-and-key-companies-by-delveinsight_568126.html","title":{"rendered":"Burkitt Lymphoma Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1633683615.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Burkitt Lymphoma Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1633683615.jpeg\" alt=\"Burkitt Lymphoma Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Burkitt Lymphoma Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Burkitt lymphoma Market<\/a> Insights, Epidemiology, and Market Forecast-2030<\/strong>&nbsp;report delivers an in-depth understanding of the Burkitt lymphoma, historical and forecasted epidemiology as well as the Burkitt lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Burkitt lymphoma is a form of non-Hodgkin&#8217;s lymphomas (NHLs) which are a group of blood cancers derived from lymphocytes. Burkitt lymphoma is a rare disease and occurs only in one in every 30-50 people with non-Hodgkin&#8217;s lymphomas. According to the World Health Organization (WHO), Burkitt lymphomas are of three types, namely, endemic, sporadic and immunodeficiency associated.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Burkitt lymphoma Market<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to WebMD, in the United States, around 1,200 new cases are diagnosed each year.<\/li>\n<li>Burkitt Lymphoma Society, the condition accounts for around 40% of the childhood non-Hodgkin lymphoma cases globally.<\/li>\n<li>It also accounts for as many as 40% of all non-Hodgkin lymphomas in HIV\/AIDS patients.<\/li>\n<li>Burkitt lymphoma (BL) may be defined as an aggressive rare disorder that constitutes approximately 1% to 2% of all non-Hodgkin lymphomas.<\/li>\n<li>Burkitt lymphoma is known as one of the most aggressive forms of lymphoma, with a doubling time of approximately 24 hours.<\/li>\n<li>According to the Cancer Research UK, 2015, around 200,000 new cases and over 140,000 deaths are estimated to be recorded each year due to EBV-associated cancers.<\/li>\n<li>According to the survey conducted by WebMD, LLC, in 2015, around 1,200 people are diagnosed each year in the U.S., of which around 59% are aged 40 years and above.<\/li>\n<li>According to the survey by Lymphoma Action Organization, 2015, around 210 people are affected by Burkitt lymphoma every year in the U.K.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burkitt-lymphoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/burkitt-lymphoma-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Burkitt lymphoma&nbsp;Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Burkitt lymphoma, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Burkitt lymphoma epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Burkitt lymphoma are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Burkitt lymphoma market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Burkitt lymphoma market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/burkitt-lymphoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/burkitt-lymphoma-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some Burkitt lymphoma Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Takeda Pharmaceutical<\/li>\n<li>Novartis AG<\/li>\n<li>Seattle Genetics, Inc<\/li>\n<li>Sanofi<\/li>\n<li>Mayo Clinic<\/li>\n<li>MethylGene Inc<\/li>\n<li>Eisai Inc<\/li>\n<li>Cellerant Therapeutics<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Burkitt lymphoma Therapies<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>RITUXIMAB<\/li>\n<li>SGN-CD19A<\/li>\n<li>Alisertib<\/li>\n<li>Clofarabine<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: https:\/\/www.delveinsight.com\/sample-request\/burkitt-lymphoma-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Burkitt lymphoma<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Burkitt lymphoma<\/p>\n<p style=\"text-align: justify;\">4. Burkitt lymphoma: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">4.1. Burkitt lymphoma Total Market Share (%) Distribution in 2018<\/p>\n<p style=\"text-align: justify;\">4.2. Burkitt lymphoma Total Market Share (%) Distribution in 2030<\/p>\n<p style=\"text-align: justify;\">5. Burkitt lymphoma: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">5.1. Introduction<\/p>\n<p style=\"text-align: justify;\">5.2. Sign and Symptoms<\/p>\n<p style=\"text-align: justify;\">5.3. Pathophysiology<\/p>\n<p style=\"text-align: justify;\">5.4. Risk Factors<\/p>\n<p style=\"text-align: justify;\">5.5. Diagnosis<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Burkitt lymphoma Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">7.1. Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">7.2. Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3. Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3.1. Burkitt lymphoma Epidemiology Scenario in the 7MM (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.4. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.4.1. Burkitt lymphoma Epidemiology Scenario in the United States (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5. EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1.1. Burkitt lymphoma Epidemiology Scenario in Germany (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.2.1. Burkitt lymphoma Epidemiology Scenario in France (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.3.1. Burkitt lymphoma Epidemiology Scenario in Italy (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.4.1. Burkitt lymphoma Epidemiology Scenario in Spain (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.5.1. Burkitt lymphoma Epidemiology Scenario in the United Kingdom (2018-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.6.1. Burkitt lymphoma Epidemiology Scenario in Japan (2018-2030)<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">8.1. Burkitt lymphoma Treatment and Management<\/p>\n<p style=\"text-align: justify;\">8.2. Burkitt lymphoma Treatment Algorithm<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Burkitt lymphoma Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">11.1. List of Marketed Products in the 7MM<\/p>\n<p style=\"text-align: justify;\">11.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">11.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">11.2.2. Regulatory Milestones<\/p>\n<p style=\"text-align: justify;\">11.2.3. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">11.2.4. Pivotal Clinical Trials<\/p>\n<p style=\"text-align: justify;\">11.2.5. Summary of Pivotal Clinical Trial<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12.1. Key Cross<\/p>\n<p style=\"text-align: justify;\">12.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">12.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">12.2.2. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">12.2.3. Clinical Development<\/p>\n<p style=\"text-align: justify;\">12.2.4. Safety and Efficacy<\/p>\n<p style=\"text-align: justify;\">12.2.5. Product Profile<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Burkitt lymphoma: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">13.1. Key Findings<\/p>\n<p style=\"text-align: justify;\">13.2. Burkitt lymphoma Market Size in 7MM<\/p>\n<p style=\"text-align: justify;\">13.3. Burkitt lymphoma Market Size by Therapies in the 7MM<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.1. United States: Market Size<\/p>\n<p style=\"text-align: justify;\">15.1.1. Burkitt lymphoma Total Market Size in the United States<\/p>\n<p style=\"text-align: justify;\">15.1.2. Burkitt lymphoma Market Size by Therapies in the United States<\/p>\n<p style=\"text-align: justify;\">15.2. EU-5 countries: Market Size and Outlook<\/p>\n<p style=\"text-align: justify;\">15.3. Germany Market Size<\/p>\n<p style=\"text-align: justify;\">15.3.1. Burkitt lymphoma Total Market Size in Germany<\/p>\n<p style=\"text-align: justify;\">15.3.2. Burkitt lymphoma Market Size by Therapies in Germany<\/p>\n<p style=\"text-align: justify;\">15.4. France Market Size<\/p>\n<p style=\"text-align: justify;\">15.4.1. Burkitt lymphoma Total Market Size in France<\/p>\n<p style=\"text-align: justify;\">15.4.2. Burkitt lymphoma Market Size by Therapies in France<\/p>\n<p style=\"text-align: justify;\">15.5. Italy Market Size<\/p>\n<p style=\"text-align: justify;\">15.5.1. Burkitt lymphoma Total Market Size in Italy<\/p>\n<p style=\"text-align: justify;\">15.5.2. Burkitt lymphoma Market Size by Therapies in Italy<\/p>\n<p style=\"text-align: justify;\">15.6. Spain Market Size<\/p>\n<p style=\"text-align: justify;\">15.6.1. Burkitt lymphoma Total Market Size in Spain<\/p>\n<p style=\"text-align: justify;\">15.6.2. Burkitt lymphoma Market Size by Therapies in Spain<\/p>\n<p style=\"text-align: justify;\">15.7. United Kingdom Market Size<\/p>\n<p style=\"text-align: justify;\">15.7.1. Burkitt lymphoma Total Market Size in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.7.2. Burkitt lymphoma Market Size by Therapies in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.8. Japan Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.8.1. Japan Market Size<\/p>\n<p style=\"text-align: justify;\">15.8.2. Burkitt lymphoma Total Market Size in Japan<\/p>\n<p style=\"text-align: justify;\">15.8.3. Burkitt lymphoma Market Size by Therapies in Japan<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Burkitt lymphoma<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">20.1. Bibliography<\/p>\n<p style=\"text-align: justify;\">20.2. Report Methodology<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Delveinsight:&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.<\/p>\n<p style=\"text-align: justify;\">Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform&nbsp;<strong>PharmDelve<\/strong>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=burkitt-lymphoma-market-industry-analysis-drugs-pipeline-treatment-and-key-companies-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/burkitt-lymphoma-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=burkitt-lymphoma-market-industry-analysis-drugs-pipeline-treatment-and-key-companies-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Burkitt Lymphoma Market DelveInsight&#8217;s&nbsp;Burkitt lymphoma Market Insights, Epidemiology, and Market Forecast-2030&nbsp;report delivers an in-depth understanding of the Burkitt lymphoma, historical and forecasted epidemiology as well as the Burkitt lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/burkitt-lymphoma-market-industry-analysis-drugs-pipeline-treatment-and-key-companies-by-delveinsight_568126.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-568126","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/568126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=568126"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/568126\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=568126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=568126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=568126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}